Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy
Clinical trial NCT02027753 · COMPLETED
Trial details
- NCT number
- NCT02027753
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2015-04-01
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.